Stock A261780 CHA VACCINE RESEARCH INSTITUTE
Add to a list
To use this feature you must be a member
Log inSign up

All News CHA Vaccine Research Institute

Equities

A261780

KR7261780001

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-27 EDT 		5-day change 1st Jan Change
4,770 KRW +0.63% Intraday chart for CHA Vaccine Research Institute +1.49% -15.58%
01-08 CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy MT
2023 Cha Vaccine Research Institute Co., Ltd. announced that it has received KRW 10 billion in funding from EBEST Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy
MT
Cha Vaccine Research Institute Co., Ltd. announced that it has received KRW 10 billion in funding from EBEST Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.
CI
Cha Vaccine Research Institute Co., Ltd. announced that it expects to receive KRW 10 billion in funding from EBEST Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.
CI
Cha Vaccine Research Institute Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Cha Vaccine Research Institute Co., Ltd. has completed an IPO in the amount of KRW 43.45 billion.
CI
Cha Vaccine Research Institute Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A261780 Stock
  4. News CHA Vaccine Research Institute